The rounds this investor is named on, who it invests beside, and where it shows up.
Named on 2 rounds in the feed.
Jeito Capital is a global leading investment company with a patient benefit driven approach that finances and accelerates ground-breaking medical innovation.
Venture capitalParis, Francejeito.lifeRounds from 2025-03-03 to 2025-05-13
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Azafaros Azafaros develops therapeutics for patients with rare metabolic disorders, particularly those affecting the lysosomal storage system. | Series B Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $146.7M | 2025-05-13 | [ LEAD ] |
Series A Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. |
| $187M |
| 2025-03-03 |
| [ PART ] |